Several other systemic inflammation markers, such as the platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), D-dimer, and lactate dehydrogenase (LDH), have been linked to prognosis in lung cancer and other solid tumors. This evidence concerns the gene CRP and lung carcinoma.